ATE64391T1 - Azacyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutisches mittel. - Google Patents

Azacyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutisches mittel.

Info

Publication number
ATE64391T1
ATE64391T1 AT89301256T AT89301256T ATE64391T1 AT E64391 T1 ATE64391 T1 AT E64391T1 AT 89301256 T AT89301256 T AT 89301256T AT 89301256 T AT89301256 T AT 89301256T AT E64391 T1 ATE64391 T1 AT E64391T1
Authority
AT
Austria
Prior art keywords
alkyl
hydrogen
group
production
pharmaceutical agent
Prior art date
Application number
AT89301256T
Other languages
English (en)
Inventor
Vittorio Vecchietti
Antonio Giordani
Original Assignee
Zambeletti Spa L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambeletti Spa L filed Critical Zambeletti Spa L
Application granted granted Critical
Publication of ATE64391T1 publication Critical patent/ATE64391T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT89301256T 1988-02-12 1989-02-09 Azacyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutisches mittel. ATE64391T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888803259A GB8803259D0 (en) 1988-02-12 1988-02-12 Compounds
EP89301256A EP0333315B1 (de) 1988-02-12 1989-02-09 Azacyclische Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als pharmazeutisches Mittel

Publications (1)

Publication Number Publication Date
ATE64391T1 true ATE64391T1 (de) 1991-06-15

Family

ID=10631593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89301256T ATE64391T1 (de) 1988-02-12 1989-02-09 Azacyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutisches mittel.

Country Status (14)

Country Link
US (1) US4994450A (de)
EP (1) EP0333315B1 (de)
JP (1) JPH01246258A (de)
KR (1) KR890012963A (de)
AT (1) ATE64391T1 (de)
AU (1) AU615984B2 (de)
DE (1) DE68900113D1 (de)
DK (1) DK65489A (de)
ES (1) ES2039845T3 (de)
GB (1) GB8803259D0 (de)
GR (1) GR3002230T3 (de)
NZ (1) NZ227930A (de)
PT (1) PT89677A (de)
ZA (1) ZA891052B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0232612B1 (de) * 1985-12-23 1990-04-04 Dr. Lo. Zambeletti S.p.A. Azacyclische Verbindungen, Verfahren zur ihrer Herstellung und ihre Verwendung als Pharmazeutika
US5512567A (en) * 1988-08-24 1996-04-30 Sankyo Company, Limited Analgesic compounds, their preparation, and pharmaceutical compositions containing them
EP0361791B1 (de) * 1988-09-26 1995-11-08 Smithkline Beecham Farmaceutici S.p.A. Azacyclische Verbindungen, verwendbar als Arzneimittel
GB8926560D0 (en) * 1989-11-24 1990-01-17 Zambeletti Spa L Pharmaceuticals
EP0447704A1 (de) * 1990-03-21 1991-09-25 Smithkline Beecham Farmaceutici S.p.A. N-Acylierte azyklische Verbindungen, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
US5428042A (en) * 1990-04-28 1995-06-27 Dr Lo Zambeletti S.P.A. 1-(2H-1-oxo-3,4-dihydronaphtyl-6-yl)-acetyl-piperidines as kappa agonists
GB9011656D0 (en) * 1990-05-24 1990-07-11 Zambeletti Spa L Novel compounds
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP2063905B1 (de) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN105299030B (zh) * 2015-11-23 2018-03-23 荣腾实业(苏州)有限公司 一种驱动轴导向机构

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052311A1 (de) * 1980-11-19 1982-05-26 Sterling Drug Inc. 1-(Benzoylphenyl-niederalkyl)-piperidine und entsprechende Carbinole und ihre Herstellung
US4656182A (en) * 1983-12-06 1987-04-07 Warner-Lambert Company Substituted trans-1,2-diaminocyclohexyl amide compounds
DE3409237A1 (de) * 1984-03-14 1985-09-19 Dr. Karl Thomae Gmbh, 7950 Biberach Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0232612B1 (de) * 1985-12-23 1990-04-04 Dr. Lo. Zambeletti S.p.A. Azacyclische Verbindungen, Verfahren zur ihrer Herstellung und ihre Verwendung als Pharmazeutika
ES2052560T3 (es) * 1986-06-05 1994-07-16 Ici America Inc Compuestos difluorcetonicos.
EP0260041B1 (de) * 1986-09-02 1991-01-30 Dr. Lo. Zambeletti S.p.A. 1-Acylsubstituierte Piperidinderivate
PT86427B (pt) * 1986-12-22 1990-11-20 Zambeletti Spa L Processo para a preparacao de derivados de piperidina

Also Published As

Publication number Publication date
US4994450A (en) 1991-02-19
EP0333315A1 (de) 1989-09-20
GB8803259D0 (en) 1988-03-09
NZ227930A (en) 1992-05-26
ZA891052B (en) 1991-03-27
AU2983489A (en) 1989-08-17
AU615984B2 (en) 1991-10-17
DK65489A (da) 1989-08-13
GR3002230T3 (en) 1992-12-30
PT89677A (pt) 1989-10-04
JPH01246258A (ja) 1989-10-02
EP0333315B1 (de) 1991-06-12
ES2039845T3 (es) 1993-10-01
KR890012963A (ko) 1989-09-20
DE68900113D1 (de) 1991-07-18
DK65489D0 (da) 1989-02-10

Similar Documents

Publication Publication Date Title
ATE64391T1 (de) Azacyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutisches mittel.
FR2673179B1 (fr) Ceramides, leur procede de preparation et leurs applications en cosmetique et en dermopharmacie.
ATE217635T1 (de) Zyklische peptide mit antifungischer wirkung und verfahren zu ihrer herstellung
RU93005057A (ru) Фармацевтические соединения, производные тиенобензодиазепина, способ их получения, фармкомпозиция и их использование
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
BG101402A (en) Apoliprotein-b synthesis inhibitors
ATE141508T1 (de) Zusammensetzung zur förderung des lipidmetabolismus
DE3867403D1 (de) L-dopa-derivate oder ihre saeureadditionssalze, verfahren zu ihrer herstellung und ihre verwendung.
IL93771A0 (en) Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs,process for the preparation thereof and pharmaceutical compositions containing the same
ATE122042T1 (de) Pyrazoloisoquinoline-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE18549T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
HUP0000894A2 (hu) Szubsztituált (1,3-bisz(ciklohexilmetil)-1,2,3,6-tetrahidro-2,6-dioxo-9H-purin-8-il)fenil-származékok és eljárás előállításukra
DE60238367D1 (de) Asymmetrischer Kupferkomplex und dessen Verwendung in Cyclopropanierungsreaktion
ATE138067T1 (de) 1,2,4-triazolo(1,5-a>pyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung
DE3864707D1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
EP0409489A3 (en) Pharmaceuticals
SE8303913L (sv) Heterocykliska foreningar
TR199902433T2 (xx) Yeni piridin t�revleri ve bunlar� i�eren ispen�iyari bile�imler.
DE3675277D1 (de) Catechinamide, verfahren zu ihrer herstellung, zwischenprodukte und pharmazeutische zubereitung.
EP0856509A3 (de) Verfahren zur Herstellung von Diacylimiden
DE3770117D1 (de) Neue 1-/ 3-(2-dialkylaminoaethoxy)-2-thienyl/-3-phenyl-1-propanone und ihre saeureadditionssalze und verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE30911T1 (de) Hydrazinopyridazinverbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE60040653D1 (de) Carbonsäurederivate und verfahren zu ihrer herstellung
DE3862426D1 (de) 2-selenomethyl-1,4-dihydropyridine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE33983T1 (de) N-substituierte tetrahydrothiazine, verfahren zu deren herstellung und deren verwendung als pestizide.